RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Teva Pharmaceutical Industries Stock

Teva Pharmaceutical Industries EBIT 2024

Teva Pharmaceutical Industries EBIT

4.3 B USD

Ticker

TEVA.TA

ISIN

IL0006290147

WKN

906517

In 2024, Teva Pharmaceutical Industries's EBIT was 4.3 B USD, a 21.53% increase from the 3.54 B USD EBIT recorded in the previous year.

The Teva Pharmaceutical Industries EBIT history

YEAREBIT (undefined USD)
2026e4.57
2025e4.49
2024e4.3
20233.54
20223.19
20213.42
20203.17
20192.75
20183.16
20173.99
20164.56
20154.74
20144.47
20133.93
20123.55
20114.01
20104.28
20093.04
20081.27
20072.4
20060.9
20051.31
20040.61

Teva Pharmaceutical Industries Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Teva Pharmaceutical Industries, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Teva Pharmaceutical Industries from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Teva Pharmaceutical Industries’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Teva Pharmaceutical Industries. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Teva Pharmaceutical Industries’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Teva Pharmaceutical Industries’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Teva Pharmaceutical Industries’s growth potential.

Teva Pharmaceutical Industries Revenue, EBIT and net profit per share

DateTeva Pharmaceutical Industries RevenueTeva Pharmaceutical Industries EBITTeva Pharmaceutical Industries Net Income
2026e17.5 B undefined4.57 B undefined3.36 B undefined
2025e17.13 B undefined4.49 B undefined3.19 B undefined
2024e16.58 B undefined4.3 B undefined2.8 B undefined
202315.85 B undefined3.54 B undefined-559 M undefined
202214.93 B undefined3.19 B undefined-2.45 B undefined
202115.88 B undefined3.42 B undefined417 M undefined
202016.66 B undefined3.17 B undefined-3.99 B undefined
201916.89 B undefined2.75 B undefined-999 M undefined
201818.85 B undefined3.16 B undefined-2.4 B undefined
201722.39 B undefined3.99 B undefined-16.53 B undefined
201621.9 B undefined4.56 B undefined68 M undefined
201519.65 B undefined4.74 B undefined1.57 B undefined
201420.27 B undefined4.47 B undefined3.06 B undefined
201320.31 B undefined3.93 B undefined1.27 B undefined
201220.32 B undefined3.55 B undefined1.96 B undefined
201118.31 B undefined4.01 B undefined2.76 B undefined
201016.12 B undefined4.28 B undefined3.33 B undefined
200913.9 B undefined3.04 B undefined2 B undefined
200811.09 B undefined1.27 B undefined635 M undefined
20079.41 B undefined2.4 B undefined1.95 B undefined
20068.41 B undefined897 M undefined546 M undefined
20055.25 B undefined1.31 B undefined1.07 B undefined
20044.8 B undefined608 M undefined332 M undefined

Teva Pharmaceutical Industries stock margins

The Teva Pharmaceutical Industries margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Teva Pharmaceutical Industries. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Teva Pharmaceutical Industries.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Teva Pharmaceutical Industries's sales revenue. A higher gross margin percentage indicates that the Teva Pharmaceutical Industries retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Teva Pharmaceutical Industries's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Teva Pharmaceutical Industries's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Teva Pharmaceutical Industries's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Teva Pharmaceutical Industries. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Teva Pharmaceutical Industries's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Teva Pharmaceutical Industries Margin History

Teva Pharmaceutical Industries Gross marginTeva Pharmaceutical Industries Profit marginTeva Pharmaceutical Industries EBIT marginTeva Pharmaceutical Industries Profit margin
2026e50.33 %26.09 %19.2 %
2025e50.33 %26.23 %18.61 %
2024e50.33 %25.95 %16.92 %
202350.33 %22.34 %-3.53 %
202249.84 %21.34 %-16.39 %
202149.53 %21.53 %2.63 %
202046.76 %19.01 %-23.95 %
201944.63 %16.27 %-5.92 %
201844 %16.73 %-12.72 %
201747.42 %17.84 %-73.82 %
201653.2 %20.81 %0.31 %
201557.79 %24.11 %8 %
201454.54 %22.06 %15.07 %
201352.71 %19.32 %6.25 %
201252.43 %17.47 %9.66 %
201151.96 %21.9 %15.07 %
201056.23 %26.56 %20.66 %
200953 %21.89 %14.39 %
200853.84 %11.45 %5.73 %
200751.84 %25.46 %20.75 %
200650.65 %10.67 %6.49 %
200547.26 %25.01 %20.42 %
200446.66 %12.67 %6.92 %

Teva Pharmaceutical Industries Aktienanalyse

What does Teva Pharmaceutical Industries do?

Teva Pharmaceutical Industries Ltd is a leading global company in the pharmaceutical industry. The company was founded in 1901 in Jerusalem, Israel, as Salomon, Levin and Company. The name Teva was adopted later in 1976. Teva's business model focuses on manufacturing and distributing high-quality and affordable pharmaceuticals worldwide. The company specializes in generics, as well as specialty pharmaceuticals. Teva has made a name for itself through its strong brand presence, focus on developing affordable medications, and production of biosimilars. Teva is divided into various divisions that focus on the manufacturing and distribution of pharmaceuticals. One of these divisions is the generics division, in which the company targets both the domestic and international markets. Teva's research and development division is known for developing biotechnology-based medications. The specialty pharmaceuticals division focuses on rare and difficult-to-treat diseases, such as multiple sclerosis and Parkinson's disease, and develops new treatment options. Teva is also commercially active in the field of biosimilars, which offer medications based on biological sources. These medications offer higher efficacy and fewer side effects than conventional medications. Teva has taken a leading role in this division by offering medications with high standards, serving a significant growth market. The company offers a variety of products, including prescription medications, over-the-counter products, and veterinary medicine. Some of Teva's popular products include Azilect (a medication for Parkinson's treatment), Copaxone (a medication for multiple sclerosis treatment), QVAR (a medication for asthma treatment), Azor (a medication for hypertension treatment), and ProAir (a medication for asthma treatment). Teva has a long-standing history in the pharmaceutical industry and has established an impressive global presence. The company has strong structures not only in Israel but also in other countries such as the United States, Europe, and Asia. It has maintained an impressive growth strategy and has become a major player in global healthcare. Overall, Teva has established itself as a key company in the pharmaceutical industry. It has a strong focus on affordability and quality of medications, with particular emphasis on the development of biosimilars and biotechnology. The company has a wide range of products and divisions that cater to the needs of customers worldwide. Teva Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Teva Pharmaceutical Industries's EBIT

Teva Pharmaceutical Industries's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Teva Pharmaceutical Industries's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Teva Pharmaceutical Industries's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Teva Pharmaceutical Industries’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Teva Pharmaceutical Industries stock

How much did Teva Pharmaceutical Industries achieve in EBIT for the current year?

In the current year, Teva Pharmaceutical Industries has achieved an EBIT of 4.3 B USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Teva Pharmaceutical Industries.

How has the EBIT of Teva Pharmaceutical Industries developed in recent years?

The EBIT of Teva Pharmaceutical Industries has increased by 21.525% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Teva Pharmaceutical Industries?

The EBIT of Teva Pharmaceutical Industries is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Teva Pharmaceutical Industries pay?

Over the past 12 months, Teva Pharmaceutical Industries paid a dividend of 3.1 USD . This corresponds to a dividend yield of about 0.18 %. For the coming 12 months, Teva Pharmaceutical Industries is expected to pay a dividend of 0 USD.

What is the dividend yield of Teva Pharmaceutical Industries?

The current dividend yield of Teva Pharmaceutical Industries is 0.18 %.

When does Teva Pharmaceutical Industries pay dividends?

Teva Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of April, July, September, December.

How secure is the dividend of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries paid dividends every year for the past 3 years.

What is the dividend of Teva Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Teva Pharmaceutical Industries located?

Teva Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Teva Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Teva Pharmaceutical Industries from 12/12/2017 amounting to 0.298 USD, you needed to have the stock in your portfolio before the ex-date on 11/28/2017.

When did Teva Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/12/2017.

What was the dividend of Teva Pharmaceutical Industries in the year 2023?

In the year 2023, Teva Pharmaceutical Industries distributed 0 USD as dividends.

In which currency does Teva Pharmaceutical Industries pay out the dividend?

The dividends of Teva Pharmaceutical Industries are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Teva Pharmaceutical Industries

Our stock analysis for Teva Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Teva Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.